Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590237 · ClinicalTrials.gov registry record · NA
KingVision Video Laryngoscopy vs Direct Laryngoscopy - Equivalence Trial
A NA study of Tracheal Intubation, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT02590237 is a NA study of Tracheal Intubation that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02590237, a NA study of Tracheal Intubation, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the Ambu KingVision videolaryngoscope performs as well as direct laryngoscopy for intubating small children and infants.
Conditions Studied
Interventions
- DEVICE Ambu KingVision Video Laryngoscope aBlade
- DEVICE Miller Direct Laryngoscopy
Study Locations (1)
Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02590237
The ClinicalTrials.gov registry entry for NCT02590237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tracheal Intubation appearing as the primary indexed condition, and to 2 interventions - of which Ambu KingVision Video Laryngoscope aBlade is the first listed.
NCT02590237 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02590237 about?
NCT02590237 is a clinical study titled "KingVision Video Laryngoscopy vs Direct Laryngoscopy - Equivalence Trial". The purpose of this study is to determine whether the Ambu KingVision videolaryngoscope performs as well as direct laryngoscopy for intubating small children and infants.
What is the current status of trial NCT02590237?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2015-10. Estimated completion is 2016-09.
What conditions does trial NCT02590237 study?
This clinical trial studies the following conditions: Tracheal Intubation.
What interventions are being tested in trial NCT02590237?
The interventions under investigation include: Ambu KingVision Video Laryngoscope aBlade (DEVICE), Miller Direct Laryngoscopy (DEVICE).
Who is sponsoring clinical trial NCT02590237?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02590237 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.